Belgian AI-powered clinical data platform LynxCare has raised €20 million in funding to accelerate the international rollout of its technology.
The Series A investment was led by Swiss healthtech investor MTIP and joined by Elaia and the company’s early-stage investors Heran Partners, BTOV, and PMV.
Since hospitals have been digitalized for some time, they have access to a vast amount of data that can be used to improve patient care and scientific research.
Technical glitches mean that 90% of the data is still unutilized.
Founded in 2015 by Georges De Feu and Dries Hens, the Belgian platform is enabling hospitals to unlock this siloed, legacy data to gain insights into the real-world performance of treatments and fuel clinical insights for doctors.
To improve patient outcomes, the company uses AI as well as Natural Language Processing (NLP).
The international rollout will be accelerated by the new funding. Georges De Feu, co-founder and CEO of LynxCare said: “We’re at the forefront of a revolution where neither medical practice nor scientific convention but the actual patients and their data will define the course of healthcare.”